MedTrace Logo

Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors

NCT03039439 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 310

Last updated 2026-05-22

No results posted yet for this study

Summary

This trial studies molecular and immunohistochemical profiling of tumors in patients with parathyroid tumors. Studying molecular and immunohistochemical profiling of tumors may help doctors avoid inconsistencies in diagnosis, unnecessary or incomplete surgery, surgical morbidity, psychological stress, and inadequate follow up.

Conditions

  • Parathyroid Gland Adenoma
  • Parathyroid Gland Atypical Adenoma
  • Parathyroid Gland Carcinoma
  • Primary Hyperparathyroidism

Interventions

PROCEDURE

Biospecimen Collection

Previously collected tumor tissue and blood samples

OTHER

Laboratory Biomarker Analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Nancy Perrier · M.D. Anderson Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-24
Primary Completion
2028-11-30
Completion
2028-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03039439 on ClinicalTrials.gov